Dimitris G. Placantonakis, MD, PhD

  • Specialty: Neurosurgery
  • Languages: English, French, Greek
  • Phone: 212-263-2441

About Me

Conditions and Treatments

brain tumor, brain cancer, glioma, astrocytoma, pituitary adenoma, brain metastasis, meningioma, craniopharyngioma, endoscopic surgery, brain mapping, CNS lymphoma, carcinomatous meningitis, pineal tumor, pituitary tumor, lumbar disc disease, spinal narrowing, hydrocephalus
Show More Conditions


  • Assistant Professor, Department of Neurosurgery
  • Dir Neurosurgical Laboratory for Stem Cell Resch
Board Certifications
  • American Board of Neurological Surgery - Neurological Surgery, 2013
Education and Training
  • Residency, Memorial Sloan-Kettering Cancer Center, Neurosurgery, 2010
  • Residency, Cornell University Medical College, Neurosurgery, 2010
  • Fellowship, Memorial Sloan-Ketteriing Cancer Center, 2008
  • MD from New York University, 2003
  • PhD from New York University, 2003

Locations and Appointments

41 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP Medicare
  • HealthSmart (WTC)
  • Healthfirst
  • Healthfirst Essential
  • Hotel Trades
  • Humana Medicare
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MultiPlan/PHCS PPO
  • NY Medicaid
  • Oscar
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • Tricare
  • UnitedHealthcare Core and Charter
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYU Neurosurgery Associates

530 1st Avenue, Suite 8R
New York, NY 10016


Phone: 212-263-2441

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

Dr. Placantonakis obtained his MD/PhD degree in Neuroscience from NYU School of Medicine and completed a postdoctoral fellowship in human embryonic stem cell biology with Drs. Lorenz Studer and Viviane Tabar at Memorial Sloan-Kettering. He was also trained in Neurosurgery at Weill Cornell Medical College and Memorial Sloan-Kettering. At NYU, he is a tenure-track physician-scientist dividing his time between his neurosurgical practice and the laboratory. Dr. Placantonakis has an interest in the treatment of gliomas and brain tumors in general. The Neurosurgical Laboratory for Stem Cell Research, which is headed by Dr. Placantonakis, studies stem cell biology in the context of glioma, a malignant brain tumor. We adapt human embryonic stem cell and genetic technologies to model oncogenic processes, with the goal of understanding the early steps in glioma formation and developing translational applications, such as high-throughput drug screening and biomarker identification. Furthermore, we use genetic approaches and patients' tissue to generate models for high-grade gliomas, with emphasis on the role of stem cells in pathogenesis and new therapeutic approaches that directly target them. Our ultimate goal is to translate our laboratory findings to new therapies and diagnostic tests for patients with glioma.

Dr. Placantonakis' laboratory is funded by the National Institutes of Health (NIH) and private foundations.


  • Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells

    Basu-Roy, Upal; Bayin, N Sumru; Rattanakorn, Kirk; Han, Eugenia; Placantonakis, Dimitris G; Mansukhani, Alka; Basilico, Claudio
    Nature communications. 2015 Apr 2. 6: 6411-6411

  • GPR133 is enriched in glioblastoma stem cells and regulates the response to hypoxia [Meeting Abstract]

    Bayin, N S; Kane, J R; Modrek, A S; Shohdy, N; MacNeil, D; Zagzag, D; Placantonakis, D G
    Neuro-oncology. 2015 November 2015. 17: v209-v209

  • Defining glioblastoma stem cell heterogeneity [Meeting Abstract]

    Bayin, N S; Sen, R; Si, S; Modrek, A S; Ortenzi, V; Zagzag, D; Snuderl, M; Golfinos, J G; Doyle, W; Galifianakis, N; Chesler, M; Illa-Bochaca, I; Barcellos-Hoff, M H; Dolgalev, I; Heguy, A; Placantonakis, D
    Neuro-oncology. 2015 November 2015. 17: v208-v209

Read All Publications (37)